Mirum(MIRM)

24.02 -0.40 -1.638%

今开:24.93昨收:24.42
最高:24.93 最低:23.85
涨停价:0.0跌停价:0.0
总市值:1.131783896E9

Mirum的热门讨论

产业链观察03-15 00:14

#药闻简讯# 美国FDA已批准$Mirum制药(MIRM)$ LIVMARLI(maralixibat)口服溶液用于治疗5岁及以上进行性家族性肝内胆汁淤积症(PFIC)患者的胆汁淤积性瘙痒。查看全文

持股变动声明

Mirum(MIRM)02-06 10:15

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002756  Size: 4 KB 网页链接查看全文

持股变动声明

Mirum(MIRM)01-26 08:15

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001825  Size: 8 KB 网页链接查看全文

年度财报

Mirum(MIRM)03-16 05:15

$Mirum制药(MIRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032289  Act: 34  Size: 15 MB 网页链接查看全文

持股变动声明

Mirum(MIRM)03-26 05:45

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046  Size: 5 KB 网页链接查看全文

其他

Mirum(MIRM)04-24 04:35

$Mirum(MIRM)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-021367  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Mirum(MIRM)02-06 10:05

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002754  Size: 5 KB 网页链接查看全文

持股变动声明

Mirum(MIRM)01-26 08:15

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001823  Size: 8 KB 网页链接查看全文

持股变动声明

Mirum(MIRM)01-26 08:15

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001824  Size: 8 KB 网页链接查看全文

持股变动声明

Mirum(MIRM)01-26 08:15

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001822  Size: 8 KB 网页链接查看全文

1 2 3

Mirum的公告

其他

$Mirum(MIRM)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-021367  Act: 34  Size: 1 MB 网页链接

股东委托书协议

$Mirum(MIRM)$ DEF 14A Other definitive proxy statements Accession Number: 0001759425-24-000011  Act: 34  Size: 1 MB 网页链接

其他

$Mirum(MIRM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001759425-24-000012  Act: 34  Size: 458 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009280  Size: 4 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009046  Size: 5 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008320  Size: 5 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008322  Size: 4 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008311  Size: 4 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008313  Size: 5 KB 网页链接

持股变动声明

$Mirum制药(MIRM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008316  Size: 6 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35